WebThe chemotherapy drugs used most often are5-fluorouracil (5-FU, Adrucil) and cisplatin (Platinol AQ). These drugs are usually given intravenously every 4 weeks. Treatment usually continues as long as the cancer doesn’t grow or spread any farther and you can cope with the side effects. Chemoradiation WebJul 13, 2024 · Adults treated with cyclophosphamide, doxorubicin, oxaliplatin, and other moderate-emetic-risk antineoplastic agents known to cause delayed nausea and …
Cisplatin (Platinol®) OncoLink
WebSep 18, 2024 · Cisplatin is a medication used to manage and treat solid tumors and hematologic malignancies. It is in the alkylating agent class of cytotoxic medications. … WebOncoLink: A multimedia oncology information resource from the University of Pennsylvania Medical Center, this site features a wealth of general information in OncoLink's Pediatric Oncology Page and disease-specific information in OncoLink's Disease-Oriented Menus. Pediatric Brain Tumor Foundation university of makati tbl hub
Chemotherapy Drug Information Chemocare.com
WebSimilarly, the overall cisplatin dose received in the JCOG trial was also lower. Only 58% of patients received at least 240 mg/m2 of cisplatin vs. 74% in the current trail. Finally, … WebJun 29, 2011 · Cisplatin is the most common agent used in combination with RT, and is one of the best studied. The standard regimen is three-weekly high-dose (100 mg/m 2) cisplatin (three cycles) concurrent with RT (2, 3). However, cisplatin at a dose of 100 mg/m 2 with concomitant RT is associated with significant acute and late toxicities (2, 4, 5). WebMar 1, 2006 · Because of the cis geometry of these bonds, cisplatin easily forms crosslinks between bases, as shown in Figure 2. Most of these cross-links are formed at sites … reasons to look for a new job